Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
This grant funds research on drug use behaviors, prevention, and health services by analyzing existing social science, behavioral, and neuroimaging data.
Funder: National Institutes of Health
Due Dates: July 17, 2025 | December 3, 2025 | July 17, 2026 | December 3, 2026 | July 15, 2027 | December 3, 2027
Funding Amounts: Up to $275,000 direct costs over 2 years (max $200,000 in any single year); 2-year project period.
Summary: Supports innovative analysis of existing data to advance research on substance use behaviors, prevention, health services, and related outcomes.
Key Information: No primary data collection allowed; clinical trials are not permitted; open to U.S. and non-U.S. organizations.
Description
This opportunity, offered by the National Institute on Drug Abuse (NIDA) at NIH, funds exploratory/developmental (R21) research projects that leverage existing social science, behavioral, administrative, and neuroimaging datasets to study the etiology and epidemiology of substance use (including alcohol, tobacco, prescription, and other drugs), related disorders, prevention (including HIV), and health service utilization. The goal is to maximize the value of previously collected data to address novel research questions, inform prevention and treatment strategies, and improve health outcomes related to substance use and HIV.
Primary data collection is not permitted under this funding opportunity. Instead, applicants are encouraged to use public, community-based, clinical, or administrative datasets, including those from NIDA-funded studies, state and local sources, or other repositories. Innovative analytic approaches, including big data analytics, computational modeling, and artificial intelligence, are strongly encouraged.
